"China Solution" of Chain Stock Released: How Will IVD MEDICAL (01931) "ETHK" Spark a Global Financial Revolution?
On September 14, the Hong Kong-listed company Huajian Medical (01931) issued two announcements in a row, causing a huge wave in the capital market. Following Europe and the United States, the market welcomed the "Chinese solution" for blockchain stocks.
On September 14th, the Hong Kong-listed company IVD MEDICAL (01931) issued two announcements, causing a huge wave in the capital market.
One announcement was about the establishment of two new companies in collaboration with partner ETHK Group - ETHK Inc. and ETHK HOLDINGS LIMITED, deepening the global on-chain financial ecosystem strategy through the core brand "ETHK". The other announcement proposed changing the company's English name from "IVD Medical Holding Limited" to "ETHK Labs Inc.", and the Chinese bilingual name from "IVD MEDICAL" to "".
These two announcements signify IVD MEDICAL's official transformation to fully embrace on-chain finance. They are focusing on promoting equity asset tokenization, including "on-chain stocks", to facilitate efficient and compliant global liquidity and value discovery, especially for high-quality assets (particularly Chinese assets).
This means that after Europe and the United States, the market is now witnessing the arrival of the "Chinese solution" for on-chain stocks.
I. IVD MEDICAL's transformation to embrace on-chain finance
IVD MEDICAL's strategic transformation is not a sudden decision, but a comprehensive elevation after long-term planning.
According to the announcements, the newly established joint venture company ETHK Inc. will focus on operating and developing the core "ETHK" brand to create a secure, efficient, compliant, and open decentralized financial platform. ETHK HOLDINGS LIMITED is positioned as an "ecological-level digital industrial investment and acquisition center", focusing on integrating industry participants, long-term capital, and licensed financial institutions globally, with a strategic focus on completing the assets, activating the capital, and strengthening compliance.
The essence of the "ETHK" brand is profound. It is derived from the fusion of "ETH - Ether" and "K - Kingdom", implying the construction of a new digital financial ecosystem based on blockchain as a medium, autonomous order, continuous innovation, and mutual prosperity.
This ecosystem is not a closed empire ruled by a single entity, but an innovative commonality and value cooperation network based on open protocols, shared infrastructure, and community governance. Its vision is rooted in the belief of "Technology for the public, the chain to carry the way", committed to creating an open, transparent, and unrestricted financial infrastructure.
IVD MEDICAL explicitly stated in the announcements that the ecosystem will focus on promoting equity asset tokenization, including "on-chain stocks", to facilitate efficient and compliant global liquidity and value discovery for high-quality assets (especially Chinese assets).
Prior to this, IVD MEDICAL announced the acquisition of a 20.31% stake in GOFINTECH, making it the largest shareholder and further strengthening its presence in the on-chain finance field. GOFINTECH QUANT has Hong Kong licenses 1, 4, 6, and 9 as well as cross-border QFI, CIBM, QDIE, QFLP, and bond connection business qualifications, providing strong compliance support for IVD MEDICAL's on-chain financial business.
II. On-chain stocks: the arrival of a new global financial revolution
"Ochain stocks" (stock tokenization) is currently the most cutting-edge trend in the global financial sector.
On September 3rd, Galaxy Digital Inc. (stock code: GLXY), a global leader in digital assets and data center infrastructure, announced a collaboration with Superstate, allowing shareholders to tokenize and hold GLXY shares on-chain. This milestone event marked the first time a listed company directly tokenized its shares registered with the U.S. Securities and Exchange Commission on a major blockchain.
Galaxy Founder and CEO Mike Novogratz stated, "Our goal is to build tokenized shares that bring the essence of cryptocurrency - transparency, programmability, and composability - into the traditional world".
Unlike tokenized products introduced by platforms such as Backed Finance and Robinhood, Galaxy Digital's collaboration is a groundbreaking stock tokenization endorsed by and directly involving a listed company, with epoch-making significance.
Previously, Robinhood launched stock token services based on Arbitrum for EU customers, covering over 200 U.S. stocks and ETFs. However, these tokenized products are issued by third-party platforms, and the target company does not endorse them. OpenAI, included by Robinhood, has publicly "drawn clear boundaries" and reminded investors that "such tokens do not represent equity".
The true value of on-chain stocks lies in their ability to achieve deep integration of traditional financial assets and blockchain technology, bringing four core advantages: enhancing liquidity, lowering investment thresholds, increasing transparency, achieving global market access, breaking geographical and national boundaries, and directing capital flow towards the most promising assets globally.
III. The "Chinese solution" for on-chain stocks
In the global wave of on-chain financial revolution, the "Chinese solution" introduced by IVD MEDICAL holds unique value and strategic significance.
IVD MEDICAL's on-chain stock solution is built on a complete ecosystem that includes not only technical infrastructure but also asset-side, capital-side, and compliance-side, forming a closed-loop on-chain financial ecosystem.
This is fundamentally different from tokenization solutions in the United States. Current stock tokenization products in the U.S., like xStocks, do not completely correlate token prices with real stock prices, creating arbitrage opportunities. As Binance founder Zhao Changpeng pointed out, "If there is a price difference between the two, investors can profit through arbitrage. But in reality, this price difference always exists, indicating that the product's mechanism is faulty".
IVD MEDICAL's ETHK ecosystem aims to achieve high throughput, millisecond-level ultra-low latency, and financial-grade security and trustworthiness by integrating next-generation high-performance blockchain underlying technology, advanced cryptography, and embedded compliance frameworks, meeting the strict requirements of high-frequency, high-value financial transactions among global institutions.
Their solution pays particular attention to the on-chain and globalization of "Chinese assets". Through stock tokenization and tokenization of bonds, credits, real estate, commodities, and other assets, high-quality Chinese assets can be "on-chained and internationalized" in a compliant and standardized manner, enhancing international recognition and allocation efficiency and widening the paths for overseas capital participation.
This aligns well with China's digital economic strategy promoted by the government. Since 2025, the country has successively issued policies such as "Several Policy Measures to Accelerate the Establishment of a Technology Financial System that Strongly Supports the High-level Self-Reliance and Self-Strengthening of Science and Technology", and "The People's Republic of China Private Economy Promotion Law", encouraging technological innovation and digital transformation. On September 11th, the State Council approved the "Comprehensive Reform Pilot Program for Market-Oriented Allocation of Factors in Some National Regions", mentioning multiple times the marketization and securitization of intellectual property.
IVD MEDICAL's strategic upgrade provides technical pathways and infrastructure support for the globalization of Chinese assets.
ConclusionThe beginning of a new financial era
The global financial system is undergoing an unprecedented digital transformation. In this transformation, IVD MEDICAL's ETHK ecosystem is expected to serve as a bridge connecting traditional finance with on-chain finance in China, facilitating the discovery of value and efficient circulation of high-quality Chinese assets globally.
On-chain stocks represent not only technological innovation but also the future direction of financial democratization and globalization. IVD MEDICAL's "Chinese solution" is laying a solid foundation for this future.
Related Articles

CHANJET (01588) obtained that the controlling shareholder reduced its holding of 42.1078 million shares, lowering its stake to approximately 53.53%.

Huatai(06886): The face interest rate of the 6th series of public issuance of corporate bonds in 2025 is 1.91%

The Deliver 2025 summit focuses on decarbonizing freight transport: Uber Technologies, Inc. partners with Tesla, Inc. (TSLA.US) to launch an electric truck project.
CHANJET (01588) obtained that the controlling shareholder reduced its holding of 42.1078 million shares, lowering its stake to approximately 53.53%.

Huatai(06886): The face interest rate of the 6th series of public issuance of corporate bonds in 2025 is 1.91%

The Deliver 2025 summit focuses on decarbonizing freight transport: Uber Technologies, Inc. partners with Tesla, Inc. (TSLA.US) to launch an electric truck project.
